pubmed-article:19464887 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19464887 | lifeskim:mentions | umls-concept:C0007600 | lld:lifeskim |
pubmed-article:19464887 | lifeskim:mentions | umls-concept:C1513095 | lld:lifeskim |
pubmed-article:19464887 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:19464887 | lifeskim:mentions | umls-concept:C0243072 | lld:lifeskim |
pubmed-article:19464887 | pubmed:issue | 13 | lld:pubmed |
pubmed-article:19464887 | pubmed:dateCreated | 2009-6-9 | lld:pubmed |
pubmed-article:19464887 | pubmed:abstractText | The synthesis of a novel series of aminoquinoline derivatives 1a-p and their antiproliferative activities against A375 human melanoma cell line were described. Most compounds showed superior antiproliferative activities to Sorafenib as a reference compound. Among them, quinolinyloxymethylphenyl compounds 1k and 1l exhibited potent activities (IC(50)=0.77 and 0.79microM, respectively) and excellent selectivity against melanoma and fibroblast cell lines. | lld:pubmed |
pubmed-article:19464887 | pubmed:language | eng | lld:pubmed |
pubmed-article:19464887 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19464887 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19464887 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19464887 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19464887 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19464887 | pubmed:month | Jul | lld:pubmed |
pubmed-article:19464887 | pubmed:issn | 1464-3405 | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:ChoiJung... | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:OhChang-HyunC... | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:KimDong JinDJ | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:ChoSeung... | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:SimTae BoTB | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:YooKyung HoKH | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:HahJung-MiJM | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:KimHwanH | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:LeeSo HaSH | lld:pubmed |
pubmed-article:19464887 | pubmed:author | pubmed-author:NamBong SooBS | lld:pubmed |
pubmed-article:19464887 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19464887 | pubmed:day | 1 | lld:pubmed |
pubmed-article:19464887 | pubmed:volume | 19 | lld:pubmed |
pubmed-article:19464887 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19464887 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19464887 | pubmed:pagination | 3517-20 | lld:pubmed |
pubmed-article:19464887 | pubmed:meshHeading | pubmed-meshheading:19464887... | lld:pubmed |
pubmed-article:19464887 | pubmed:meshHeading | pubmed-meshheading:19464887... | lld:pubmed |
pubmed-article:19464887 | pubmed:meshHeading | pubmed-meshheading:19464887... | lld:pubmed |
pubmed-article:19464887 | pubmed:meshHeading | pubmed-meshheading:19464887... | lld:pubmed |
pubmed-article:19464887 | pubmed:meshHeading | pubmed-meshheading:19464887... | lld:pubmed |
pubmed-article:19464887 | pubmed:meshHeading | pubmed-meshheading:19464887... | lld:pubmed |
pubmed-article:19464887 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19464887 | pubmed:articleTitle | Aminoquinoline derivatives with antiproliferative activity against melanoma cell line. | lld:pubmed |
pubmed-article:19464887 | pubmed:affiliation | Life Sciences Research Division, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul 130-650, Republic of Korea. | lld:pubmed |
pubmed-article:19464887 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19464887 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19464887 | lld:chembl |